Boehringer Ingelheim-backed COVID researchers identify new antibodies to fight the virus

In April, Boehringer Ingelheim announced a multifaceted plan to help fight COVID-19, which included collaborating with academic researchers to find potential treatments. Now one of those research programs has uncovered 28 antibodies that the company plans to move into further testing.